We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current GLMD market cap is 672k. The company's latest EPS is USD -4.1143 and P/E is -0.09.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.38M | -2.45M | -2M | -1.87M | -1.47M |
| Net Income | -5.35M | -2.64M | -1.83M | -1.59M | -1.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.38M | -30.21M | -32.88M | -17.65M | -7.49M |
| Net Income | -20.46M | -28.77M | -32.47M | -17.87M | -6.91M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.87M | 16.56M | 14.79M | 13.28M | 17.64M |
| Total Liabilities | 5.12M | 3.14M | 2.8M | 2.72M | 2.09M |
| Total Equity | 15.75M | 13.42M | 11.99M | 10.55M | 15.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 77.14M | 52.38M | 36.61M | 16.56M | 16.63M |
| Total Liabilities | 7.29M | 8.23M | 6.11M | 3.14M | 2.75M |
| Total Equity | 69.85M | 44.15M | 30.5M | 13.42M | 13.88M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.48M | -18.5M | -1.7M | -3.06M | -5.24M |
| Investing | 15.58M | 17.56M | 1.35M | 2.06M | -1.48M |
| Financing | 70k | 70k | N/A | N/A | 6.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.94M | -26.29M | -32.89M | -18.5M | -6.14M |
| Investing | 6.68M | 16.54M | 11.46M | 17.56M | 800k |
| Financing | 143k | 768k | 17.37M | 70k | 6.19M |
| Market Cap | 672k |
| Price to Earnings Ratio | -0.09 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.23 |
| Price to Book Ratio | 0.05 |
| Dividend Yield | - |
| Shares Outstanding | 1.68M |
| Average Volume (1 week) | 37.15k |
| Average Volume (1 Month) | 255.17k |
| 52 Week Change | -91.38% |
| 52 Week High | 7.80 |
| 52 Week Low | 0.26 |
| Spread (Intraday) | 0.02 (5.25%) |
| Company Name | Galmed Pharmaceuticals Ltd |
| Address |
16 tiomkin street tel aviv, center 6578317 |
| Website | https://www.galmedpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
